全文获取类型
收费全文 | 6788篇 |
免费 | 633篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 86篇 |
儿科学 | 255篇 |
妇产科学 | 181篇 |
基础医学 | 785篇 |
口腔科学 | 197篇 |
临床医学 | 728篇 |
内科学 | 1318篇 |
皮肤病学 | 64篇 |
神经病学 | 687篇 |
特种医学 | 197篇 |
外科学 | 791篇 |
综合类 | 185篇 |
一般理论 | 5篇 |
预防医学 | 848篇 |
眼科学 | 64篇 |
药学 | 579篇 |
中国医学 | 4篇 |
肿瘤学 | 454篇 |
出版年
2023年 | 40篇 |
2022年 | 42篇 |
2021年 | 105篇 |
2020年 | 70篇 |
2019年 | 122篇 |
2018年 | 108篇 |
2017年 | 109篇 |
2016年 | 114篇 |
2015年 | 120篇 |
2014年 | 155篇 |
2013年 | 222篇 |
2012年 | 360篇 |
2011年 | 380篇 |
2010年 | 184篇 |
2009年 | 191篇 |
2008年 | 303篇 |
2007年 | 300篇 |
2006年 | 288篇 |
2005年 | 280篇 |
2004年 | 332篇 |
2003年 | 271篇 |
2002年 | 248篇 |
2001年 | 217篇 |
2000年 | 220篇 |
1999年 | 185篇 |
1998年 | 82篇 |
1997年 | 73篇 |
1996年 | 79篇 |
1995年 | 66篇 |
1994年 | 63篇 |
1993年 | 54篇 |
1992年 | 142篇 |
1991年 | 121篇 |
1990年 | 181篇 |
1989年 | 126篇 |
1988年 | 100篇 |
1987年 | 127篇 |
1986年 | 106篇 |
1985年 | 126篇 |
1984年 | 106篇 |
1983年 | 96篇 |
1981年 | 50篇 |
1979年 | 78篇 |
1978年 | 44篇 |
1977年 | 50篇 |
1976年 | 57篇 |
1974年 | 62篇 |
1973年 | 41篇 |
1972年 | 51篇 |
1969年 | 39篇 |
排序方式: 共有7428条查询结果,搜索用时 15 毫秒
91.
Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer. 总被引:7,自引:0,他引:7
Timothy Kuo Cheryl D Cho Joanne Halsey Heather A Wakelee Ranjana H Advani James M Ford George A Fisher Branimir I Sikic 《Journal of clinical oncology》2005,23(24):5613-5619
PURPOSE: To investigate the gefitinib, fluorouracil (FU), leucovorin, and oxaliplatin regimen (IFOX) in previously treated patients with metastatic colorectal cancer. PATIENTS AND METHODS: Eligible patients had stage IV colorectal adenocarcinoma and had demonstrated progression or intolerance to a prior chemotherapy regimen not including oxaliplatin. Each cycle consisted of 14 days. Cycle 1 consisted of oxaliplatin 85 mg/m2 intravenously (IV) during 2 hours on day 1, hours 0 to 2; leucovorin 200 mg/m2 IV on days 1 and 2, hours 0 to 2; FU 400 mg/m2 IV push on days 1 and 2; and FU 600 mg/m2 IV on days 1 and 2, hours 2 to 24 (FOLFOX-4). All subsequent cycles consisted of FOLFOX-4 with gefitinib at 500 mg/d administered orally throughout the 14-day cycle. RESULTS: Twenty-seven patients were enrolled onto the study. The median number of prior chemotherapy regimens was two, and 74% of all patients received prior irinotecan. Nine of the 27 patients (33%) and six of the 20 patients (30%) who had prior FU and irinotecan had a partial response by Response Evaluation Criteria in Solid Tumors Group criteria. Median overall survival was 12.0 months. Median event-free survival was 5.4 months. Grade 3 to 4 toxicities included neutropenia (48%), diarrhea (48%), nausea (22%), and vomiting (15%). CONCLUSION: IFOX is an active regimen in patients with previously treated metastatic colorectal adenocarcinoma, demonstrating higher response rates than those reported with FOLFOX-4 alone in a similar patient population. 相似文献
92.
Anna M. Hood Allison A. King Melanie E. Fields Andria L. Ford Kristin P. Guilliams Monica L. Hulbert Jin‐Moo Lee Desiree A. White 《Pediatric blood & cancer》2019,66(10)
Individuals with sickle cell disease (SCD) experience cognitive deficits; however, it remains unclear whether medical treatments for SCD improve cognition. Given that executive abilities are typically impaired in individuals with SCD, they were the focus of the current study. Our primary hypothesis was that executive abilities would be higher acutely soon after a blood transfusion in children and young adults with SCD. We used tests from the NIH Toolbox to assess executive abilities in 27 participants with SCD receiving chronic transfusion in comparison to 34 participants with SCD receiving hydroxyurea (HU) and 41 non‐SCD demographically matched controls, all of whom were tested at two time points. Participants in the transfusion group completed cognitive testing within 3 days after a transfusion (soon after transfusion) and then within 3 days before their next transfusion (long after transfusion) over an interval of 3‐7 weeks. We found that executive abilities were significantly poorer for the transfusion and HU groups than for the control group. In support of our primary hypothesis, executive abilities for the transfusion group were significantly better soon after a transfusion compared to long after a transfusion, χ2(1) = 17.8, P < .0001. Our results demonstrate that executive abilities were higher acutely following a blood transfusion. These findings have implications for daily functioning, medical decision making, and academic achievement in children and young adults with SCD. 相似文献
93.
Proteins of human placental microvilli: II. Identification and topology of the plasma membrane proteins 总被引:1,自引:0,他引:1
We have investigated the location of proteins in the transverse plane of the plasma membrane of microvilli isolated from the syncytiotrophoblast layer of the human term placenta. Microvillous proteins were labelled with 125I under reaction conditions where those proteins exposed on the maternal-facing surface of the microvilli were most heavily labelled. The proteins were then solubilized and subjected to one- and two-dimensional electrophoresis followed by protein staining and autoradiography. More than 65 proteins, differing in molecular weight or isoelectric point or both, were identified, and these were classified into three groups: weakly, moderately heavily, and heavily labelled. The microvilli were in the form of intact vesicles that were correctly orientated ('right-side out'). Thus the extent of labelling of each protein could be used as an indication of the extent of its exposure on the maternal-facing surface of the microvilli. Human serum albumin was present on the surface of the isolated, washed microvilli, but was probably a contaminant originating from maternal blood. 相似文献
94.
Iron overload disorders: treatment options for patients refractory to or intolerant of phlebotomy 总被引:1,自引:0,他引:1
Iron overload disorders involve excess accumulation of iron in body tissues as a result of hereditary and nonhereditary diseases. If left untreated, tissue iron deposition can result in organ damage. Treatment options such as phlebotomy, chelating agents, and erythrocytapheresis can prevent complications and target organ damage. Although phlebotomy is the gold standard for iron overload treatment in the setting of hereditary hemochromatosis, this procedure is usually not feasible for other iron overload conditions, especially those associated with anemia. With the introduction of newer, oral chelating agents, more options are available for patients refractory to or intolerant of parenteral chelating agents. 相似文献
95.
96.
Gutiérrez-Puente Y Tari AM Ford RJ Tamez-Guerra R Mercado-Hernandez R Santoyo-Stephano M Lopez-Berestein G 《Leukemia & lymphoma》2003,44(11):1979-1985
A P-ethoxy oligonucleotide (oligo), 20 bases long and specific for the translation initiation site of human Bcl-2 mRNA, was incorporated into liposomes to increase its intracellular delivery. This oligo selectively inhibited Bcl-2 protein expression and induced growth inhibition in t(14;18)-positive transformed follicular lymphoma (FL) cell lines. We studied the inhibitory effects of shorter liposomal P-ethoxy oligos (7, 9, 11 or 15 mer) in order to determine the activity of different oligo chain lengths targeted to the same Bcl-2 mRNA. At 12 μM, all the oligos inhibited the growth of a FL cell line. We compared the 7-mer oligo with the 20-mer oligo. The two oligos inhibited Bcl-2 protein expression similarly: 66% and 60% for the 7- and 20-mer, respectively. The uptake and retention of both oligos were also very similar. Our results indicate that the Bcl-2 inhibitory activity is maintained with P-ethoxy antisense oligos ranging from 7 to 20 bases. 相似文献
97.
98.
Ford NM 《Reproductive biomedicine online》2008,17(Z3):39-48
This article presents the Catholic Christian tradition and teaching on the moral respect due to human life from conception, supported by natural law moral philosophical reasoning. This approach contrasts with the ethical views of secular philosophers on human embryo research for therapeutic purposes. The challenges for Catholic healthcare institutions is to find ethical ways of using suitable pluripotent stem cells for therapies without creating or destroying human embryos. Catholic teaching on infertility treatment and reproductive technology are presented with emphasis given to the ethical need for children to be conceived and born of the marriage union compared with alterative ethical approaches for the use of infertility treatment and reproductive technology. 相似文献
99.
PURPOSE OF REVIEW: Human epidemiological and animal studies show that many chronic adult conditions have their antecedents in compromised fetal and early postnatal development. Developmental programming is defined as the response by the developing mammalian organism to a specific challenge during a critical time window that alters the trajectory of development with resulting persistent effects on phenotype. Mammals pass more biological milestones before birth than any other time in their lives. Each individual's phenotype is influenced by the developmental environment as much as their genes. A better understanding is required of gene-environment interactions leading to adult disease. RECENT FINDINGS: During development, there are critical periods of vulnerability to suboptimal conditions when programming may permanently modify disease susceptibility. Programming involves structural changes in important organs; altered cell number, imbalance in distribution of different cell types within the organ, and altered blood supply or receptor numbers. Compensatory efforts by the fetus may carry a price. Effects of programming may pass across generations by mechanisms that do not necessarily involve structural gene changes. Programming often has different effects in males and females. SUMMARY: Developmental programming shows that epigenetic factors play major roles in development of phenotype and predisposition to disease in later life. 相似文献
100.